Virtu KCG Holdings’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $41K | Sell |
14,238
-29,716
| -68% | -$85.6K | ﹤0.01% | 2625 |
|
|
2017
Q1 | $151K | Buy |
43,954
+10,139
| +30% | +$34.8K | ﹤0.01% | 2528 |
|
|
2016
Q4 | $59K | Buy |
33,815
+10,193
| +43% | +$17.8K | ﹤0.01% | 3034 |
|
|
2016
Q3 | $78K | Sell |
23,622
-2,849
| -11% | -$9.41K | ﹤0.01% | 2688 |
|
|
2016
Q2 | $114K | Buy |
26,471
+18,486
| +232% | +$79.6K | ﹤0.01% | 2496 |
|
|
2016
Q1 | $45K | Sell |
7,985
-1,107
| -12% | -$6.24K | ﹤0.01% | 2477 |
|
|
2015
Q4 | $156K | Buy |
9,092
+7,252
| +394% | +$124K | ﹤0.01% | 2318 |
|
|
2015
Q3 | $39K | Sell |
1,840
-1,404
| -43% | -$29.8K | ﹤0.01% | 2575 |
|
|
2015
Q2 | $161K | Buy |
3,244
+1,686
| +108% | +$83.7K | ﹤0.01% | 2220 |
|
|
2015
Q1 | $122K | Sell |
1,558
-4,689
| -75% | -$367K | ﹤0.01% | 2099 |
|
|
2014
Q4 | $379K | Sell |
6,247
-2,311
| -27% | -$140K | 0.01% | 1393 |
|
|
2014
Q3 | $365K | Buy |
8,558
+3,198
| +60% | +$136K | 0.01% | 1420 |
|
|
2014
Q2 | $331K | Sell |
5,360
-876
| -14% | -$54.1K | 0.01% | 1628 |
|
|
2014
Q1 | $405K | Buy |
+6,236
| New | +$405K | 0.01% | 1218 |
|
|
2013
Q4 | – | Sell |
-5,973
| Closed | -$366K | – | 3399 |
|
|
2013
Q3 | $366K | Buy |
+5,973
| New | +$366K | ﹤0.01% | 1510 |
|